121 related articles for article (PubMed ID: 9524924)
41. An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide.
Scotland RS; Chauhan S; Vallance PJ; Ahluwalia A
Hypertension; 2001 Oct; 38(4):833-9. PubMed ID: 11641295
[TBL] [Abstract][Full Text] [Related]
42. Nitric oxide modulates acetylcholine-induced vasodilatation in the hepatic arterial vasculature of the dual-perfused rat liver.
Yang W; Benjamin IS; Alexander B
Acta Physiol Scand; 2001 Apr; 171(4):413-8. PubMed ID: 11421856
[TBL] [Abstract][Full Text] [Related]
43. Effect of NG-nitro-L-arginine-methyl-ester on cardiopulmonary function and biosynthesis of cyclooxygenase products during porcine endotoxemia.
Hellyer PW; Johnson LW; Olson NC
Crit Care Med; 1997 Jun; 25(6):1051-8. PubMed ID: 9201060
[TBL] [Abstract][Full Text] [Related]
44. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
de la Cruz JP; Moreno A; Ruiz-Ruiz MI; García-Campos J; Sánchez de la Cuesta F
Eur J Pharmacol; 1998 Oct; 360(1):37-42. PubMed ID: 9845270
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
46. Involvement of platelet-activating factor in cell death induced under ischemia/postischemia-like conditions in an immortalized hippocampal cell line.
Shi LC; Wang HY; Friedman E
J Neurochem; 1998 Mar; 70(3):1035-44. PubMed ID: 9489723
[TBL] [Abstract][Full Text] [Related]
47. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes.
Silva CL; Cruz HN; Violante FA; Cordeiro RS; Martins MA; Noël F
Biochem Pharmacol; 1996 Jan; 51(2):193-6. PubMed ID: 8615889
[TBL] [Abstract][Full Text] [Related]
48. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
[TBL] [Abstract][Full Text] [Related]
49. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
Hu W; McNicholl IK; Choy PC; Man RY
Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
[TBL] [Abstract][Full Text] [Related]
50. Platelet-activating factor. A possible role in the modulation of the vasomotor tone and blood pressure.
Lopes-Martins RA; Araújo CV; Estato V; Moreira S; Cordeiro RS; Tibiriçá EV
Adv Exp Med Biol; 1996; 416():223-30. PubMed ID: 9131152
[No Abstract] [Full Text] [Related]
51. Responses of rat postganglionic sympathetic vasoconstrictor neurons following blockade of nitric oxide synthesis in vivo.
Häbler HJ; Wasner G; Bartsch T; Jänig W
Neuroscience; 1997 Apr; 77(3):899-909. PubMed ID: 9070761
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary arterial pressure and electrocardiograms in broiler chickens infused intravenously with L-NAME, an inhibitor of nitric oxide synthase, or sodium nitroprusside (SNP), a nitric oxide donor.
Weidong S; Xiaolong W; Jinyong W; Ruiping X
Br Poult Sci; 2002 May; 43(2):306-12. PubMed ID: 12047097
[TBL] [Abstract][Full Text] [Related]
53. Intestinal and hepatic perfusion and metabolism in hypodynamic endotoxic shock. Effects of nitric oxide synthase inhibition.
Dahm PL; Thörne J; Myhre E; Grins E; Mårtensson L; Blomquist S
Acta Anaesthesiol Scand; 1999 Jan; 43(1):56-63. PubMed ID: 9926190
[TBL] [Abstract][Full Text] [Related]
54. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
[TBL] [Abstract][Full Text] [Related]
55. Exogenous nitric oxide centrally enhances pulmonary reactivity in the normal and hypertensive rat.
Schwenke DO; Pearson JT; Tsuchimochi H; Mori H; Shirai M
Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):952-9. PubMed ID: 16405452
[TBL] [Abstract][Full Text] [Related]
56. Dissociation between the increase in systemic vascular resistance induced by acute nitric oxide synthesis inhibition and the decrease in cardiac output in anesthetized dogs.
Zappellini A; Moreno Júnior H; Antunes E; de Nucci G
J Cardiovasc Pharmacol; 1997 Jan; 29(1):45-8. PubMed ID: 9007669
[TBL] [Abstract][Full Text] [Related]
57. Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor.
Claing A; Bkaily G; Berthiaume N; Sirois P; Rola-Pleszczynski M; D'Orléans-Juste P
Br J Pharmacol; 1994 Aug; 112(4):1202-8. PubMed ID: 7952882
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological mechanisms involved in the vasodilator effects of extracts from Echinodorus grandiflorus.
Tibiriçá E; Almeida A; Caillleaux S; Pimenta D; Kaplan MA; Lessa MA; Figueiredo MR
J Ethnopharmacol; 2007 Apr; 111(1):50-5. PubMed ID: 17150321
[TBL] [Abstract][Full Text] [Related]
59. Effect of nitric oxide modulation on systemic haemodynamics and platelet activation determined by P-selectin expression.
Ritchie JL; Alexander HD; Allen P; Morgan D; McVeigh GE
Br J Haematol; 2002 Mar; 116(4):892-8. PubMed ID: 11886397
[TBL] [Abstract][Full Text] [Related]
60. Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats.
Varagic J; Jerkic M; Jovovic D; Nastic-Miric D; Adanja-Grujic G; Markovic-Lipkovski J; Lackovic V; Radujkovic-Kuburovic G; Kentera D
Am J Med Sci; 2000 Sep; 320(3):171-6. PubMed ID: 11014370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
